Humacyte Inc. (HUMAW)

0.98

-0.07 (-6.67%)

At close: Mar 03, 2025, 3:57 PM

0.92

-6.50%

After-hours: Mar 03, 2025, 03:58 PM EST

Humacyte Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-110.78M	-11.96M	-26.48M	-66.52M	-85.42M
Depreciation & Amortization	7.72M	8.21M	8.24M	8.35M	6.75M
Stock-Based Compensation	6.83M	6.18M	10.15M	4.69M	4.46M
Other Working Capital	1.73M	1.39M	-116K	289K	638K
Other Non-Cash Items	16.35M	-74.41M	-54.74M	103K	1.98M
Deferred Income Tax	n/a	-173K	-17.8M	177K	-4.27M
Change in Working Capital	6.57M	1.03M	-557K	-2.37M	453K
Operating Cash Flow	-73.31M	-71.13M	-81.19M	-55.57M	-71.79M
Capital Expenditures	-2.28M	-1.05M	-220K	-318K	-8.13M
Acquisitions	n/a	-5.89M	n/a	50K	n/a
Purchase of Investments	n/a	-10.11M	-8M	n/a	n/a
Sales Maturities Of Investments	2.11M	16M	n/a	n/a	n/a
Other Investing Acitivies	n/a	5.89M	-8M	50K	n/a
Investing Cash Flow	-173K	4.84M	-8.22M	-268K	-8.13M
Debt Repayment	-34.07M	-1.98M	27.93M	1.75M	-1.29M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	38.57M	535K	239.05M	301K	1.22M
Financial Cash Flow	4.51M	-1.45M	266.98M	2.05M	-74K
Net Cash Flow	-68.97M	-67.73M	177.57M	-53.78M	-79.99M
Free Cash Flow	-75.58M	-72.18M	-81.41M	-55.89M	-79.91M